Diadema Partners »

Meiragtx Holdings shares owned by Diadema Partners

Quarter-by-quarter ownership of Meiragtx Holdings (MGTX) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Meiragtx Holdings

Tip: Access up to 7 years of quarterly data

All positions including Meiragtx Holdings held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Meiragtx Holdings by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $120k 8.9k 13.51

More positions owned by Diadema Partners

Abivax Sa Sponsored Ads Call Option (ABVX)
Viking Therapeutics (VKTX)
Bristol Myers Squibb Put Option (BMY)
Amgen Call Option (AMGN)
United Therapeutics Corporation (UTHR)
Revolution Medicines (RVMD)
Uniqure Nv SHS Put Option (QURE)
Novartis Sponsored Adr Call Option (NVS)
Kodiak Sciences Call Option (KOD)
Capricor Therapeutics Com New Put Option (CAPR)
Cogent Biosciences (COGT)
Bridgebio Pharma Note 1.750% 3/0 (Principal)
Corcept Therapeutics Incorporated Call Option (CORT)
BioMarin Pharmaceutical (BMRN)
Kymera Therapeutics Call Option (KYMR)

View all positions for Diadema Partners

Top funds holding Meiragtx Holdings

Sanofi
Perceptive Advisors
Rubric Capital Management
Johnson & Johnson
BlackRock
Adage Capital Partners GP
Opaleye Management
Millennium Management
683 Capital Management
Morgan Stanley
Woodline Partners
Knoll Capital Management
Kennedy Capital Management
Long Focus Capital Management
Jacobs Levy Equity Management

View all funds holding Meiragtx Holdings